Evaluates impurity and degradation of iptacopan, suggesting a robust quality control method.
≥ 0.9995), precision (%RSD ≤ 0.75), accuracy (98.32%-100.26%), and robustness. Forced degradation studies generated four distinct degradation products (DPs) under acidic and oxidative stress, characterized by LC-MS/MS. DP 3 showed a +30-Da mass increase (m/z 453.4996), consistent with an indole-carboxylic acid analogue, whereas DP 1 (m/z 439.4730) exhibited a -14-Da shift, indicating demethylation. DP 2 displayed a -42-Da difference (m/z 381.4369) due to dealkylation, and DP 4 showed a +14-Da shift (m/z 437.5002), corresponding to a linker ketone analogue. In silico toxicity assessment suggested moderate toxicity for most DPs, with DP 4 showing a comparatively favorable profile. Greenness and whiteness evaluation using AGREE (0.82), AGREE-Prep (0.81), GAPI (E-factor = 10), and RGB-12 (78.0%) confirmed excellent environmental and practical performance. The method provides a robust and sustainable platform for quality control and stability assessment of iptacopan.
No takes yet. Share an insight, caveat, or question.
Jaggavarapu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: